Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
Børge G. Nordestgaard, MD, DMSc
Kausik Ray, MBChB, MD, MPhil
FCS: Enhancing the Diagnosis
Daniel Gaudet, MD, PhD
SHTG: Decoding the Latest Clinical Trial Outcomes
Pam R. Taub, MD, FACC, FASPC
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Jan T. Kielstein, MD, FASN, FERA
Novel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Riccardo Maria Inciardi, MD, PhD
Cristina Gavina, MD, PhD
Giuseppe Galati, MD
Understanding hypertrophic cardiomyopathy and recent guidelines
Elena Arbelo, MD, PhD
Echocardiographic workup for HCM – making the diagnosis and evaluation of cardiac function
Thor Edvardsen, MD, PhD
Role of echocardiography in risk stratification and treatment decision-making
Maurizio Pieroni, MD, PhD
Echo essentials for HCM: The heartbeat of diagnosis and treatment
Optimizing AAV Outcomes: Maintenance Therapies
Bernhard Hellmich, MD
Silke R. Brix, MD, MRCP, SCPR
Pearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD
Matthew R. Weir, MD
Nihar R. Desai, MD, MPH
Ellie Kelepouris, MD, FACP, FAHA
Trade off: Ischemic/Thrombotic vs Bleeding
Renato D. Lopes, MD, MHS, PhD
Elevating Care for Patients With Severe Renal Disease in AAV
Andreas Kronbichler, MD
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
Alexander T. Cohen, MD, MBBS
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Valeria Caso, MD, PhD
Loading...
We're glad to see you're enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.